Jun 18, 2020
Genetic Medicine will be the Solution to COVID-19, and Ligandal is Leading the way
Jun 05, 2020
U.S. Support for Drugmakers Fuels Effort to Secure Shortest Timeline for COVID-19 Vaccine
Jun 04, 2020
INOVIO and IVI Partner with Seoul National University Hospital to Start Phase 1/2 Clinical Trial of INOVIO's COVID-19 DNA Vaccine (INO-4800) in South Korea
May 20, 2020
INOVIO's COVID-19 DNA Vaccine INO-4800 Demonstrates Robust Neutralizing Antibody and T Cell Immune Responses in Preclinical Models
Apr 28, 2020
INOVIO Completes Enrollment in the Phase 1 U.S. Trial of INO-4800 for COVID-19 DNA Vaccine; Interim Results Expected in June
Apr 28, 2020
INOVIO and GeneOne Life Science Report Positive Phase 1/2a Clinical Data With DNA Vaccine INO-4700 for MERS Coronavirus at the American Society of Gene & Cell Therapy (ASGCT) Conference
Apr 06, 2020
INOVIO Initiates Phase 1 Clinical Trial Of Its COVID-19 Vaccine and Plans First Dose Today
Mar 30, 2020
Johnson & Johnson Announces a Lead Vaccine Candidate for COVID-19; Landmark New Partnership with U.S. Department of Health & Human Services; and Commitment to Supply One Billion Vaccines Worldwide for Emergency Pandemic Use
Feb 03, 2020
HIV Vaccine Trial HVTN 702 Stopped Early for Non-Efficacy; Other Vaccine Trials Not Affected; AVAC Calls for Ongoing Support to Vaccine Research
Jan 30, 2020
Inovio Collaborating With Beijing Advaccine To Advance INO-4800 Vaccine Against New Coronavirus In China
Nov 12, 2019
 IAVI Announces Award from U.S. Department of Defense to Advance Marburg Virus Vaccine Candidate Development
Sep 17, 2019
Inovio Receives NIH Funding to Target its dMAb® Technology Against Antimicrobial-Resistant Infection
Jul 25, 2019
Inovio's Positive First-in-Human MERS Vaccine Results Published in The Lancet Infectious Diseases
Jun 13, 2019
Pivotal ECHO Study Provides Reassuring Evidence on HIV Risk and Contraceptives
Jun 10, 2019
Inovio Receives $8.14 Million Award to Support Further Development of its Commercial Skin Delivery Device
May 21, 2019
Inovio First to Advance Lassa Fever Candidate Vaccine Into a Clinical Trial
May 08, 2019
Animal Vaccines Market Would Register a CAGR of 5.7% From 2018 to 2025
Apr 29, 2019
Mymetics receives HIV Vaccine Funding from the NIH
Mar 21, 2019
Inovio's Ebola Vaccine Delivered Intradermally Demonstrates 100% Immunogenicity in a Clinical Study Published in The Journal of Infectious Diseases
Mar 05, 2019
Inovio Pharmaceuticals to Announce Fourth Quarter and Full Year 2018 Financial Results and Host Conference Call on March 12, 2019